Market Exclusive

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) had its Buy rating reiterated by JPMorgan Chase & Co.

Analyst Ratings For ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

Today, JPMorgan Chase & Co. reiterated its Buy rating on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD).

There are 8 Buy Ratings, 3 Hold Ratings, 1 Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is Buy with a consensus target price of $43.8333 per share, a potential 12.83% upside.

Some recent analyst ratings include

Recent Trading Activity for ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
Shares of ACADIA Pharmaceuticals Inc. closed the previous trading session at 38.85 up +15.05 63.24% with 41.75 shares trading hands.

Exit mobile version